Dais Newsfeed | 30/01/2021 07:46 PM | Click to read full article
Serum Institute of India, the world's biggest vaccine maker, is hopeful of launching Covovax - developed in partnership with American vaccine developer Novavax - by June, its CEO Adar Poonawalla said today. The US-based pharma firm's Covid jab was found to be 89.3 per cent effective in a UK trial.
“We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!" Adar Poonawalla tweeted